泰恩康(301263)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

301263 泰恩康

已收盘 07-19 15:00:00

{"stockData":{"symbol":"301263","market":"SZ","secType":"STK","nameCN":"泰恩康","latestPrice":12.4,"timestamp":1721372580000,"preClose":12.2,"halted":0,"volume":2136062,"delay":0,"floatShares":268000000,"shares":425000000,"eps":0.3612,"marketStatus":"已收盘","marketStatusCode":5,"change":0.2,"latestTime":"07-19 15:00:00","open":12.2,"high":12.56,"low":12.12,"amount":26476700,"amplitude":0.0361,"askPrice":12.4,"askSize":12,"bidPrice":12.39,"bidSize":100,"shortable":0,"etf":0,"ttmEps":0.3612,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1721611800000},"adr":0,"adjPreClose":12.2,"symbolType":"stock","openAndCloseTimeList":[[1721352600000,1721359800000],[1721365200000,1721372400000]],"highLimit":13.42,"lowLimit":10.98,"ibTradeSell":false,"ibTradeBuySell":false,"totalEquity":425497500,"pbRate":2.83,"roa":"--","roe":"2.51%","epsLYR":0.38,"committee":-0.36035,"marketValue":5276000000,"floatMarketCap":3319000000,"peRate":34.330011,"changeRate":0.0164,"turnoverRate":0.008,"status":0},"requestUrl":"/m/hq/s/301263/wiki","defaultTab":"wiki","newsList":[{"id":"2452131363","title":"泰恩康最新公告：全资子公司收到两项功能性载体辅料登记","url":"https://stock-news.laohu8.com/highlight/detail?id=2452131363","media":"证券之星","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2452131363?lang=zh_cn&edition=full","pubTime":"2024-07-17 18:11","pubTimestamp":1721211068,"startTime":"0","endTime":"0","summary":"泰恩康公告，公司全资子公司山东华铂凯盛生物科技有限公司(以下简称\"华铂凯盛\")于近日分别收到1项国家药品监督管理局(以下简称\"国家药监局\")医疗器械技术审评中心签发的左旋聚乳酸医疗器械主文档登记回执；1项国家药监局药品审评中心签发的药用辅料甲氧基聚乙二醇-聚谷氨酸钠(供注射用)登记。以上内容由证券之星根据公开信息整理，由算法生成（网信算备310104345710301240019号），与本站立场无关，如数据存在问题请联系我们。本文为数据整理，不对您构成任何投资建议，投资有风险，请谨慎决策。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024071700037837.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0250","301263"],"gpt_icon":0},{"id":"2452804371","title":"泰恩康(301263.SZ)收到两项功能性载体辅料登记","url":"https://stock-news.laohu8.com/highlight/detail?id=2452804371","media":"智通财经","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2452804371?lang=zh_cn&edition=full","pubTime":"2024-07-17 16:50","pubTimestamp":1721206258,"startTime":"0","endTime":"0","summary":"智通财经APP讯，泰恩康(301263.SZ)发布公告，公司全资子公司山东华铂凯盛生物科技有限公司(简称“华铂凯盛”)于近日分别收到1项国家药品监督管理局医疗器械技术审评中心签发的左旋聚乳酸医疗器械主文档登记回执;1项国家药监局药品审评中心签发的药用辅料甲氧基聚乙二醇-聚谷氨酸钠(供注射用)登记。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1152049.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK0250","301263"],"gpt_icon":0},{"id":"2451660119","title":"泰恩康(301263.SZ)：利多卡因丙胺卡因气雾剂获药物临床试验批准","url":"https://stock-news.laohu8.com/highlight/detail?id=2451660119","media":"智通财经","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2451660119?lang=zh_cn&edition=full","pubTime":"2024-07-16 17:49","pubTimestamp":1721123375,"startTime":"0","endTime":"0","summary":"智通财经APP讯，泰恩康(301263.SZ)公告，公司全资子公司山东华铂凯盛生物科技有限公司(简称“华铂凯盛”)于近日收到国家药品监督管理局签发的《药物临床试验批准通知书》，同意华铂凯盛提交的利多卡因丙胺卡因气雾剂临床试验的申请。公告显示，利多卡因丙胺卡因气雾剂是一种局部麻醉药物，主要用于治疗成年男性原发性早泄问题，临床疗效明确，使用方便。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1151580.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1583","BK1141","03347","301263","BK1576","BK0250"],"gpt_icon":0},{"id":"2448438944","title":"天风证券：给予泰恩康买入评级，目标价位16.5元","url":"https://stock-news.laohu8.com/highlight/detail?id=2448438944","media":"证券之星","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2448438944?lang=zh_cn&edition=full","pubTime":"2024-07-04 17:50","pubTimestamp":1720086642,"startTime":"0","endTime":"0","summary":"天风证券股份有限公司杨松近期对泰恩康进行研究并发布了研究报告《两性健康药物快速放量，胃肠用药有望迎来拐点》，本报告对泰恩康给出买入评级，认为其目标价位为16.50元，当前股价为12.15元，预期上涨幅度为35.8%。最新盈利预测明细如下：该股最近90天内共有1家机构给出评级，买入评级1家。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024070400035182.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["301263","601162"],"gpt_icon":0},{"id":"2446575945","title":"泰恩康6月28日现1笔大宗交易 成交金额1000万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2446575945","media":"智能小浪","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2446575945?lang=zh_cn&edition=full","pubTime":"2024-06-28 17:00","pubTimestamp":1719565200,"startTime":"0","endTime":"0","summary":"　　6月28日，泰恩康收涨0.40%，收盘价为12.53元，发生1笔大宗交易，合计成交量100万股，成交金额1000万元。　　进一步统计，近3个月内该股累计发生10笔大宗交易，合计成交金额为1.36亿元。该股近5个交易日累计下跌3.09%，主力资金合计净流出127.52万元。","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"sina","url":"https://finance.sina.com.cn/stock/ggzz/2024-06-28/doc-incahqxn6103166.shtml","rn_cache_url":null,"customStyle":"body{padding-top:10px;}.art_tit_h1{#titleStyle#}a{#lv2TextColor#}.art_time, .art_cite{#sourceStyle#;} .art_cite{margin-left: 3px;}","selectors":".module-article, article","filters":"header, .voice2, .tags, #norm_qrcode_link_auto, .unfold-box, .action","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/ggzz/2024-06-28/doc-incahqxn6103166.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["301263","BK0250"],"gpt_icon":0},{"id":"2446520775","title":"6月28日泰恩康现1笔折价20.19%的大宗交易 合计成交1000万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2446520775","media":"证券之星","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2446520775?lang=zh_cn&edition=full","pubTime":"2024-06-28 16:30","pubTimestamp":1719563445,"startTime":"0","endTime":"0","summary":"证券之星消息，6月28日泰恩康发生大宗交易，交易数据如下：大宗交易成交价格10元，相对当日收盘价折价20.19%，成交100万股，成交金额1000万元，买方营业部为中国银河证券股份有限公司广州长堤证券营业部，卖方营业部为西南证券股份有限公司重庆奉节永安路证券营业部。近三个月该股共发生10笔大宗交易，合计成交11.83万手，折价成交10笔。截至2024年6月28日收盘，泰恩康报收于12.53元，上涨0.4%，换手率0.37%，成交量9801.0手，成交额1226.55万元。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024062800033931.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["301263","BK0250"],"gpt_icon":0},{"id":"2446936091","title":"泰恩康(301263.SZ)：盐酸毛果芸香碱滴眼液用于成人老视患者III期临床完成首例受试者入组","url":"https://stock-news.laohu8.com/highlight/detail?id=2446936091","media":"智通财经","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2446936091?lang=zh_cn&edition=full","pubTime":"2024-06-26 20:34","pubTimestamp":1719405261,"startTime":"0","endTime":"0","summary":"智通财经APP讯，泰恩康(301263.SZ)公告，近日，公司全资子公司山东华铂凯盛生物科技有限公司(“华铂凯盛”)组织开展的盐酸毛果芸香碱滴眼液用于成人老视患者的III期临床试验完成首例受试者入组。根据2020年世界卫生组织公布的《世界视觉报告》，全球老视患病人数达到18亿。据悉，盐酸毛果芸香碱滴眼液(1.25%)由艾伯维(Abbvie)旗下公司艾尔建(Allergan)研制，于2021年获美国FDA批准上市，适用于治疗成人老视，商品名为VUITY®，是全球首款用于治疗老视的药物。截至公告披露日，国内尚无同类产品获批上市。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1141111.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK4134","301263","III","BK0250"],"gpt_icon":0},{"id":"2446605323","title":"泰恩康最新公告：盐酸毛果芸香碱滴眼液III期临床试验完成首例受试者入组","url":"https://stock-news.laohu8.com/highlight/detail?id=2446605323","media":"证券之星","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2446605323?lang=zh_cn&edition=full","pubTime":"2024-06-26 20:30","pubTimestamp":1719405016,"startTime":"0","endTime":"0","summary":"泰恩康公告，近日，公司全资子公司山东华铂凯盛生物科技有限公司组织开展的盐酸毛果芸香碱滴眼液用于成人老视患者的III期临床试验完成首例受试者入组。截至目前，国内尚无同类产品获批上市。以上内容由证券之星根据公开信息整理，由算法生成（网信算备310104345710301240019号），与本站立场无关，如数据存在问题请联系我们。本文为数据整理，不对您构成任何投资建议，投资有风险，请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024062600041218.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["301263","BK1141","03347","BK1576","BK0250","BK1583"],"gpt_icon":0},{"id":"2446892786","title":"泰恩康6月25日现1笔大宗交易 成交金额550万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2446892786","media":"智能小浪","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2446892786?lang=zh_cn&edition=full","pubTime":"2024-06-25 17:00","pubTimestamp":1719306000,"startTime":"0","endTime":"0","summary":"　　6月25日，泰恩康收涨0.48%，收盘价为12.55元，发生1笔大宗交易，合计成交量55万股，成交金额550万元。　　进一步统计，近3个月内该股累计发生9笔大宗交易，合计成交金额为1.26亿元。该股近5个交易日累计下跌3.68%，主力资金合计净流出204.14万元。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"sina","url":"https://finance.sina.com.cn/stock/ggzz/2024-06-25/doc-inazxxuh1415314.shtml","rn_cache_url":null,"customStyle":"body{padding-top:10px;}.art_tit_h1{#titleStyle#}a{#lv2TextColor#}.art_time, .art_cite{#sourceStyle#;} .art_cite{margin-left: 3px;}","selectors":".module-article, article","filters":"header, .voice2, .tags, #norm_qrcode_link_auto, .unfold-box, .action","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/ggzz/2024-06-25/doc-inazxxuh1415314.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["BK0250","301263"],"gpt_icon":0},{"id":"2446891961","title":"6月25日泰恩康现1笔折价20.32%的大宗交易 合计成交550万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2446891961","media":"证券之星","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2446891961?lang=zh_cn&edition=full","pubTime":"2024-06-25 16:40","pubTimestamp":1719304845,"startTime":"0","endTime":"0","summary":"证券之星消息，6月25日泰恩康发生大宗交易，交易数据如下：大宗交易成交价格10元，相对当日收盘价折价20.32%，成交55万股，成交金额550万元，买方营业部为中国银河证券股份有限公司汕头澄海证券营业部，卖方营业部为西南证券股份有限公司重庆奉节永安路证券营业部。近三个月该股共发生9笔大宗交易，合计成交10.83万手，折价成交9笔。截至2024年6月25日收盘，泰恩康报收于12.55元，上涨0.48%，换手率0.53%，成交量1.42万手，成交额1774.53万元。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024062500031162.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0250","301263"],"gpt_icon":0},{"id":"2445355557","title":"6月21日泰恩康现1笔折价20.34%的大宗交易 合计成交1030万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2445355557","media":"证券之星","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2445355557?lang=zh_cn&edition=full","pubTime":"2024-06-21 16:40","pubTimestamp":1718959237,"startTime":"0","endTime":"0","summary":"证券之星消息，6月21日泰恩康发生大宗交易，交易数据如下：大宗交易成交价格10.3元，相对当日收盘价折价20.34%，成交100万股，成交金额1030万元，买方营业部为中国银河证券股份有限公司汕头澄海证券营业部，卖方营业部为西南证券股份有限公司重庆奉节永安路证券营业部。近三个月该股共发生8笔大宗交易，合计成交10.28万手，折价成交8笔。截至2024年6月21日收盘，泰恩康报收于12.93元，上涨1.25%，换手率0.53%，成交量1.43万手，成交额1852.77万元。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024062100034144.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["301263","BK0250"],"gpt_icon":0},{"id":"2445973565","title":"泰恩康6月21日现1笔大宗交易 成交金额1030万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2445973565","media":"智能小浪","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2445973565?lang=zh_cn&edition=full","pubTime":"2024-06-21 16:40","pubTimestamp":1718959200,"startTime":"0","endTime":"0","summary":"　　6月21日，泰恩康收涨1.25%，收盘价为12.93元，发生1笔大宗交易，合计成交量100万股，成交金额1030万元。　　进一步统计，近3个月内该股累计发生8笔大宗交易，合计成交金额为1.21亿元。该股近5个交易日累计上涨0.15%，主力资金合计净流出50.84万元。","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"sina","url":"https://finance.sina.com.cn/stock/ggzz/2024-06-21/doc-inazntae1286820.shtml","rn_cache_url":null,"customStyle":"body{padding-top:10px;}.art_tit_h1{#titleStyle#}a{#lv2TextColor#}.art_time, .art_cite{#sourceStyle#;} .art_cite{margin-left: 3px;}","selectors":".module-article, article","filters":"header, .voice2, .tags, #norm_qrcode_link_auto, .unfold-box, .action","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/ggzz/2024-06-21/doc-inazntae1286820.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["301263","BK0250"],"gpt_icon":0},{"id":"2444118435","title":"6月18日泰恩康发布公告，其股东减持79.01万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2444118435","media":"证券之星","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2444118435?lang=zh_cn&edition=full","pubTime":"2024-06-18 22:00","pubTimestamp":1718719248,"startTime":"0","endTime":"0","summary":"证券之星消息，6月18日泰恩康发布公告《泰恩康:关于股东股份减持计划期限届满的公告》，其股东深圳市聚兰德股权投资基金合伙企业(有限合伙)于2024年3月19日至2024年6月18日间合计减持79.01万股，占公司目前总股本的0.1857%，变动期间该股股价下跌11.36%，截止6月18日收盘报13.03元。股东增减持详情见下表：根据泰恩康2024年一季报公布的十大股东详情如下：以上内容由证券之星根据公开信息整理，由算法生成（网信算备310104345710301240019号），与本站立场无关，如数据存在问题请联系我们。本文为数据整理，不对您构成任何投资建议，投资有风险，请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024061800040716.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0250","301263"],"gpt_icon":0},{"id":"2444040482","title":"泰恩康(301263.SZ)股东聚兰德共减持79.01万股 减持期满","url":"https://stock-news.laohu8.com/highlight/detail?id=2444040482","media":"智通财经","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2444040482?lang=zh_cn&edition=full","pubTime":"2024-06-18 20:45","pubTimestamp":1718714744,"startTime":"0","endTime":"0","summary":"智通财经APP讯，泰恩康(301263.SZ)发布公告，截至2024年6月18日，股东聚兰德本次减持计划时间已届满，其本次减持共计79.01万股，减持比例0.1866%","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1137046.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK0250","301263"],"gpt_icon":0},{"id":"2444524191","title":"泰恩康最新公告：控股子公司自研1类创新药CKBA软膏已完成50%受试者入组","url":"https://stock-news.laohu8.com/highlight/detail?id=2444524191","media":"证券之星","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2444524191?lang=zh_cn&edition=full","pubTime":"2024-06-17 18:11","pubTimestamp":1718619091,"startTime":"0","endTime":"0","summary":"泰恩康公告，控股子公司博创园组织开展的用于治疗白癜风适应症的1类创新药物CKBA软膏已按照II期临床方案完成50%受试者的入组。以上内容由证券之星根据公开信息整理，由算法生成（网信算备310104345710301240019号），与本站立场无关，如数据存在问题请联系我们。本文为数据整理，不对您构成任何投资建议，投资有风险，请谨慎决策。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024061700022481.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["159992","BK1161","BK0250","301263","BK1574","06978"],"gpt_icon":0},{"id":"2443564612","title":"泰恩康6月14日现1笔大宗交易 成交金额663.16万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2443564612","media":"智能小浪","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2443564612?lang=zh_cn&edition=full","pubTime":"2024-06-14 17:00","pubTimestamp":1718355600,"startTime":"0","endTime":"0","summary":"　　6月14日，泰恩康收跌1.15%，收盘价为12.91元，发生1笔大宗交易，合计成交量63.4万股，成交金额663.16万元。　　进一步统计，近3个月内该股累计发生7笔大宗交易，合计成交金额为1.1亿元。该股近5个交易日累计上涨2.30%，主力资金合计净流出128.52万元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"sina","url":"https://finance.sina.com.cn/stock/ggzz/2024-06-14/doc-inayszph2853198.shtml","rn_cache_url":null,"customStyle":"body{padding-top:10px;}.art_tit_h1{#titleStyle#}a{#lv2TextColor#}.art_time, .art_cite{#sourceStyle#;} .art_cite{margin-left: 3px;}","selectors":".module-article, article","filters":"header, .voice2, .tags, #norm_qrcode_link_auto, .unfold-box, .action","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/ggzz/2024-06-14/doc-inayszph2853198.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["301263","BK0250"],"gpt_icon":0},{"id":"2443564310","title":"6月14日泰恩康现1笔折价18.98%的大宗交易 合计成交663.16万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2443564310","media":"证券之星","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2443564310?lang=zh_cn&edition=full","pubTime":"2024-06-14 16:40","pubTimestamp":1718354419,"startTime":"0","endTime":"0","summary":"证券之星消息，6月14日泰恩康发生大宗交易，交易数据如下：大宗交易成交价格10.46元，相对当日收盘价折价18.98%，成交63.4万股，成交金额663.16万元，买方营业部为中国银河证券股份有限公司汕头澄海证券营业部，卖方营业部为西南证券股份有限公司重庆奉节永安路证券营业部。近三个月该股共发生7笔大宗交易，合计成交9.28万手，折价成交7笔。截至2024年6月14日收盘，泰恩康报收于12.91元，下跌1.15%，换手率0.5%，成交量1.35万手，成交额1742.93万元。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024061400030591.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0250","301263"],"gpt_icon":0},{"id":"2442743352","title":"泰恩康6月11日现1笔大宗交易 成交金额2082万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2442743352","media":"智能小浪","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2442743352?lang=zh_cn&edition=full","pubTime":"2024-06-11 17:00","pubTimestamp":1718096400,"startTime":"0","endTime":"0","summary":"　　6月11日，泰恩康收涨2.62%，收盘价为13.33元，发生1笔大宗交易，合计成交量200万股，成交金额2082万元。　　进一步统计，近3个月内该股累计发生5笔大宗交易，合计成交金额为9451.2万元。该股近5个交易日累计下跌0.97%，主力资金合计净流入1090.21万元。","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"sina","url":"https://finance.sina.com.cn/stock/ggzz/2024-06-11/doc-inaykeaa3914223.shtml","rn_cache_url":null,"customStyle":"body{padding-top:10px;}.art_tit_h1{#titleStyle#}a{#lv2TextColor#}.art_time, .art_cite{#sourceStyle#;} .art_cite{margin-left: 3px;}","selectors":".module-article, article","filters":"header, .voice2, .tags, #norm_qrcode_link_auto, .unfold-box, .action","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/ggzz/2024-06-11/doc-inaykeaa3914223.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["BK0250","301263"],"gpt_icon":0},{"id":"2442351558","title":"6月11日泰恩康现1笔折价21.91%的大宗交易 合计成交2082万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2442351558","media":"证券之星","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2442351558?lang=zh_cn&edition=full","pubTime":"2024-06-11 16:34","pubTimestamp":1718094851,"startTime":"0","endTime":"0","summary":"证券之星消息，6月11日泰恩康发生大宗交易，交易数据如下：大宗交易成交价格10.41元，相对当日收盘价折价21.91%，成交200万股，成交金额2082万元，买方营业部为中国银河证券股份有限公司汕头澄海证券营业部，卖方营业部为西南证券股份有限公司重庆奉节永安路证券营业部。近三个月该股共发生5笔大宗交易，合计成交7.8万手，折价成交5笔。截至2024年6月11日收盘，泰恩康报收于13.33元，上涨2.62%，换手率1.0%，成交量2.67万手，成交额3518.81万元。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024061100019772.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0250","301263"],"gpt_icon":0},{"id":"2441065641","title":"泰恩康：6月6日高管李挺增持股份合计4.54万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2441065641","media":"证券之星","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2441065641?lang=zh_cn&edition=full","pubTime":"2024-06-07 21:02","pubTimestamp":1717765352,"startTime":"0","endTime":"0","summary":"证券之星消息，根据6月7日市场公开信息、上市公司公告及交易所披露数据整理，泰恩康最新董监高及相关人员股份变动情况：2024年6月6日公司董秘,董事,高管李挺共增持公司股份4.54万股，占公司总股本为0.0107%。泰恩康近半年内的董监高及核心技术人员增减持详情如下：泰恩康的高管列表及最新持股情况如下：融资融券数据显示该股近5日融资净流入2252.81万，融资余额增加；融券净流入0.0，融券余额增加。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024060700046516.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["301263","BK0250"],"gpt_icon":0}],"profile":{"ret":0,"listingDate":"2022-03-29","address":"广东省汕头市龙湖区泰山北路万吉南二街8号A幢","stockEarnings":[{"period":"1week","weight":0.0065},{"period":"1month","weight":-0.0476},{"period":"3month","weight":-0.0434},{"period":"6month","weight":-0.1494},{"period":"1year","weight":-0.382},{"period":"ytd","weight":-0.225}],"companyName":"广东泰恩康医药股份有限公司","boardCode":"AI0051","perCapita":"21774股","boardName":"批发业","registeredCapital":"42549万元","compareEarnings":[{"period":"1week","weight":0.0037},{"period":"1month","weight":-0.0118},{"period":"3month","weight":-0.0271},{"period":"6month","weight":0.053},{"period":"1year","weight":-0.0591},{"period":"ytd","weight":0.0025}],"survey":"　　广东泰恩康医药股份有限公司主营业务为代理运营及研发、生产、销售医药产品、医疗器械、卫生材料并提供医药技术服务与技术转让等。公司的主要产品包括处方药、OTC、医疗器械、卫生材料、医药技术服务等。","serverTime":1721478637272,"listedPrice":19.93,"stockholders":"12294人(较上一季度减少4.56%)","compareStock":{"symbol":"000001.SH","name":"上证指数"}},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.25.1","shortVersion":"4.25.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"泰恩康(301263)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供泰恩康(301263)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"泰恩康,301263,泰恩康股票,泰恩康股票老虎,泰恩康股票老虎国际,泰恩康行情,泰恩康股票行情,泰恩康股价,泰恩康股市,泰恩康股票价格,泰恩康股票交易,泰恩康股票购买,泰恩康股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"泰恩康(301263)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供泰恩康(301263)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}